Month: April 2026

The joint article by PeriPharm and Duchesnay, published in the Journal of Obstetrics and Gynaecology Canada, reveals significant gaps in access to women’s health innovations and shows that Canadian women wait more than three years to access them

BLAINVILLE, QC, April 22, 2026 /PRNewswire/ – Duchesnay, a Canadian specialty pharmaceutical company with a long-standing commitment to women’s health, member of Duchesnay Pharmaceutical Group (DPG), and PeriPharm, a Canadian company specializing in pharmacoeconomics and outcomes research, are proud to announce the publication of an article in the Journal of Obstetrics and Gynaecology Canada (JOGC) to raise awareness regarding significant barriers and years‑long delays in accessing innovative medications for women’s health in Canada. This paper is based on a comprehensive analysis of the women’s health products in Canada covering a 20-year period (from January 1, 2003, to December 31, 2023), conducted by PeriPharm, for which Duchesnay has provided the financial support.

The results, presented at the Femtech Canada Forum in Vancouver last November, which drew significant interest and engagement from attendees, reveal a concerning trend: public coverage for women’s health medications lags about one year behind coverage for other medications, leaving many Canadian women reliant on private insurance to access optimal care.  

“This study reflects the long-standing experiences of many women who are seeking more timely access to treatments already available internationally,” said Rachel Bartholomew, Founder and Lead Advisor, Femtech Canada. “Disparities in access to innovations in women’s health can significantly impact outcomes, quality of life, and overall long-term wellbeing of Canadian women.”

This study is the first to provide a quantitative evaluation of the main challenges involved in bringing innovative women’s health medications to Canada over the past 20 years. The research found that of the 45 women’s health medications approved by the U.S. Food and Drug Administration between 2003 and 2023 only 24 were approved in Canada. Even when medications do receive approval, the path to public coverage is resource-intensive and non-uniform. On average, it takes more than three years for a newly approved women’s health medication to appear on at least one Canadian public formulary, a full year longer than the average for other medications. Fewer than two-thirds of women’s health treatments approved by Health Canada are ultimately reimbursed through public drug plans.

“To ensure Canadian women have timely access to innovative therapies, it is essential to prioritize women’s health within Canada’s regulatory and reimbursement system,” said Catherine Beauchemin, Ph.D., partner at PeriPharm and co-author of the article. “We hope that these findings will help advance patient-centered policies and ultimately elevate the quality of care women receive across the country.”

Some of this study’s findings align with those of Azzarello D and Collins J. who, in 2004, conducted an analysis on access to hormonal contraceptive options in Canada¹. Following the Guidance for Industry: Clinical Development of Steroidal Contraceptives Used by Women issued by Health Canada on October 29, 2002, Canadian women had access to only 37% of the hormonal contraceptive choices available worldwide. Strikingly, this level of access has remained unchanged over the past two decades.

“Innovation is at the heart of Duchesnay, and I’m very proud to be part of a Canadian pharmaceutical company that invests in women’s health. This study shed the light on important evidence of the situation of women in Canada as funding remains limited,” said Édith Sirard, Director, Sales and Marketing, Duchesnay, and co-author of the article. “Modernizing the regulatory and reimbursement landscape is critical so that Canadian women can benefit from advances in care. At Duchesnay, we believe that women should have access to the most effective therapies available so that they can reach their full potential.”

The current study aims to lay the groundwork for a structural revision of current regulatory and reimbursement policies, while also facilitating in-depth discussions on key improvements, such as stronger recognition of women’s health needs, better integration of patient perspectives, and enhanced coordination between federal and provincial decision-makers, to drive meaningful changes across the healthcare ecosystem. Without such reforms, the decades long pattern of limited access to innovation in women’s health will likely persist.

ABOUT PERIPHARM

Founded in 2003, PeriPharm is a Canadian company specializing in pharmacoeconomics and outcomes research. The company’s mission is to provide high-quality, diversified services to ensure optimal market access of health care innovations. PeriPharm’s activity is built on the belief the best available therapies should be accessible to those who need it. As a leader in the field of health economics and data generation, PeriPharm has contributed to the success of several market access initiatives. 

For more information about PeriPharm, please visit https://peripharm.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY

Duchesnay is a specialty pharmaceutical company with a long-standing commitment to women’s health. Until recently, the company focused on filling the void in terms of scientific research and education and on developing pharmacological solutions that are safe and effective for use during pregnancy and breastfeeding.

Today, Duchesnay has broadened its portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives. Believing that women around the world deserve to have access to specialized treatments for their conditions, Duchesnay now distributes its products internationally. We strive to enable each woman to reach her full potential.

For more information about Duchesnay, please visit https://duchesnay.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY PHARMACEUTICAL GROUP

Duchesnay Pharmaceutical Group (DPG), with its affiliated companies, is headquartered in Blainville, Quebec. The Group consists of six pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad. The companies are Duchesnay (Canada) and Duchesnay USA, both dedicated to women’s health; Medunik Canada and Medunik USA, which provide treatments for rare and debilitating diseases; and Analog Pharma Canada and Analog Pharma, specializing in orphan generic medications. From its state-of-the-art manufacturing plant, DPG exports its innovative treatments to more than 50 countries.

DPG is one of the eight companies across the country chosen to participate in the Government of Canada’s Global Hypergrowth Project. This appointment offers exclusive and personalized support for at least two years, in order to accelerate its growth to become an anchor firm in the Canadian economy.

DPG is the winner of the 2024 Life Sciences Innovation Award by ADRIQ, the Association for the Development of Research and Innovation of Quebec, which recognizes DPG’s healthy workplace culture and commitment to pharmaceutical innovation, while DPG president Éric Gervais is the recipient of the 2024 Bernard-Landry Award by ADRIQ which acknowledges his impactful leadership on Quebec’s research and innovation ecosystem.

DPG, through its proprietary research and development, and through exclusive partnerships, offers innovative treatments for a variety of medical conditions in women’s health, urology, oncology and for rare diseases, plus lower-cost generic medications. DPG recognizes the dedication and professionalism of its employees and promotes a positive culture and flexible work environment. It is deeply committed to environmental responsibility and to giving back to the community through the support of various charitable organizations.

For more information, please visit https://duchesnaypharmaceuticalgroup.com/en.

Follow us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/duchesnay-and-peripharm-emphasize-the-need-to-update-regulatory-and-reimbursement-policies-to-improve-access-to-innovations-in-womens-health-302749510.html

SOURCE Duchesnay inc.

The joint article by PeriPharm and Duchesnay, published in the Journal of Obstetrics and Gynaecology Canada, reveals significant gaps in access to women’s health innovations and shows that Canadian women wait more than three years to access them

BLAINVILLE, QC, April 22, 2026 /PRNewswire/ – Duchesnay, a Canadian specialty pharmaceutical company with a long-standing commitment to women’s health, member of Duchesnay Pharmaceutical Group (DPG), and PeriPharm, a Canadian company specializing in pharmacoeconomics and outcomes research, are proud to announce the publication of an article in the Journal of Obstetrics and Gynaecology Canada (JOGC) to raise awareness regarding significant barriers and years‑long delays in accessing innovative medications for women’s health in Canada. This paper is based on a comprehensive analysis of the women’s health products in Canada covering a 20-year period (from January 1, 2003, to December 31, 2023), conducted by PeriPharm, for which Duchesnay has provided the financial support.

The results, presented at the Femtech Canada Forum in Vancouver last November, which drew significant interest and engagement from attendees, reveal a concerning trend: public coverage for women’s health medications lags about one year behind coverage for other medications, leaving many Canadian women reliant on private insurance to access optimal care.  

“This study reflects the long-standing experiences of many women who are seeking more timely access to treatments already available internationally,” said Rachel Bartholomew, Founder and Lead Advisor, Femtech Canada. “Disparities in access to innovations in women’s health can significantly impact outcomes, quality of life, and overall long-term wellbeing of Canadian women.”

This study is the first to provide a quantitative evaluation of the main challenges involved in bringing innovative women’s health medications to Canada over the past 20 years. The research found that of the 45 women’s health medications approved by the U.S. Food and Drug Administration between 2003 and 2023 only 24 were approved in Canada. Even when medications do receive approval, the path to public coverage is resource-intensive and non-uniform. On average, it takes more than three years for a newly approved women’s health medication to appear on at least one Canadian public formulary, a full year longer than the average for other medications. Fewer than two-thirds of women’s health treatments approved by Health Canada are ultimately reimbursed through public drug plans.

“To ensure Canadian women have timely access to innovative therapies, it is essential to prioritize women’s health within Canada’s regulatory and reimbursement system,” said Catherine Beauchemin, Ph.D., partner at PeriPharm and co-author of the article. “We hope that these findings will help advance patient-centered policies and ultimately elevate the quality of care women receive across the country.”

Some of this study’s findings align with those of Azzarello D and Collins J. who, in 2004, conducted an analysis on access to hormonal contraceptive options in Canada¹. Following the Guidance for Industry: Clinical Development of Steroidal Contraceptives Used by Women issued by Health Canada on October 29, 2002, Canadian women had access to only 37% of the hormonal contraceptive choices available worldwide. Strikingly, this level of access has remained unchanged over the past two decades.

“Innovation is at the heart of Duchesnay, and I’m very proud to be part of a Canadian pharmaceutical company that invests in women’s health. This study shed the light on important evidence of the situation of women in Canada as funding remains limited,” said Édith Sirard, Director, Sales and Marketing, Duchesnay, and co-author of the article. “Modernizing the regulatory and reimbursement landscape is critical so that Canadian women can benefit from advances in care. At Duchesnay, we believe that women should have access to the most effective therapies available so that they can reach their full potential.”

The current study aims to lay the groundwork for a structural revision of current regulatory and reimbursement policies, while also facilitating in-depth discussions on key improvements, such as stronger recognition of women’s health needs, better integration of patient perspectives, and enhanced coordination between federal and provincial decision-makers, to drive meaningful changes across the healthcare ecosystem. Without such reforms, the decades long pattern of limited access to innovation in women’s health will likely persist.

ABOUT PERIPHARM

Founded in 2003, PeriPharm is a Canadian company specializing in pharmacoeconomics and outcomes research. The company’s mission is to provide high-quality, diversified services to ensure optimal market access of health care innovations. PeriPharm’s activity is built on the belief the best available therapies should be accessible to those who need it. As a leader in the field of health economics and data generation, PeriPharm has contributed to the success of several market access initiatives. 

For more information about PeriPharm, please visit https://peripharm.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY

Duchesnay is a specialty pharmaceutical company with a long-standing commitment to women’s health. Until recently, the company focused on filling the void in terms of scientific research and education and on developing pharmacological solutions that are safe and effective for use during pregnancy and breastfeeding.

Today, Duchesnay has broadened its portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives. Believing that women around the world deserve to have access to specialized treatments for their conditions, Duchesnay now distributes its products internationally. We strive to enable each woman to reach her full potential.

For more information about Duchesnay, please visit https://duchesnay.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY PHARMACEUTICAL GROUP

Duchesnay Pharmaceutical Group (DPG), with its affiliated companies, is headquartered in Blainville, Quebec. The Group consists of six pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad. The companies are Duchesnay (Canada) and Duchesnay USA, both dedicated to women’s health; Medunik Canada and Medunik USA, which provide treatments for rare and debilitating diseases; and Analog Pharma Canada and Analog Pharma, specializing in orphan generic medications. From its state-of-the-art manufacturing plant, DPG exports its innovative treatments to more than 50 countries.

DPG is one of the eight companies across the country chosen to participate in the Government of Canada’s Global Hypergrowth Project. This appointment offers exclusive and personalized support for at least two years, in order to accelerate its growth to become an anchor firm in the Canadian economy.

DPG is the winner of the 2024 Life Sciences Innovation Award by ADRIQ, the Association for the Development of Research and Innovation of Quebec, which recognizes DPG’s healthy workplace culture and commitment to pharmaceutical innovation, while DPG president Éric Gervais is the recipient of the 2024 Bernard-Landry Award by ADRIQ which acknowledges his impactful leadership on Quebec’s research and innovation ecosystem.

DPG, through its proprietary research and development, and through exclusive partnerships, offers innovative treatments for a variety of medical conditions in women’s health, urology, oncology and for rare diseases, plus lower-cost generic medications. DPG recognizes the dedication and professionalism of its employees and promotes a positive culture and flexible work environment. It is deeply committed to environmental responsibility and to giving back to the community through the support of various charitable organizations.

For more information, please visit https://duchesnaypharmaceuticalgroup.com/en.

Follow us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/duchesnay-and-peripharm-emphasize-the-need-to-update-regulatory-and-reimbursement-policies-to-improve-access-to-innovations-in-womens-health-302749510.html

SOURCE Duchesnay inc.

The joint article by PeriPharm and Duchesnay, published in the Journal of Obstetrics and Gynaecology Canada, reveals significant gaps in access to women’s health innovations and shows that Canadian women wait more than three years to access them

BLAINVILLE, QC, April 22, 2026 /PRNewswire/ – Duchesnay, a Canadian specialty pharmaceutical company with a long-standing commitment to women’s health, member of Duchesnay Pharmaceutical Group (DPG), and PeriPharm, a Canadian company specializing in pharmacoeconomics and outcomes research, are proud to announce the publication of an article in the Journal of Obstetrics and Gynaecology Canada (JOGC) to raise awareness regarding significant barriers and years‑long delays in accessing innovative medications for women’s health in Canada. This paper is based on a comprehensive analysis of the women’s health products in Canada covering a 20-year period (from January 1, 2003, to December 31, 2023), conducted by PeriPharm, for which Duchesnay has provided the financial support.

The results, presented at the Femtech Canada Forum in Vancouver last November, which drew significant interest and engagement from attendees, reveal a concerning trend: public coverage for women’s health medications lags about one year behind coverage for other medications, leaving many Canadian women reliant on private insurance to access optimal care.  

“This study reflects the long-standing experiences of many women who are seeking more timely access to treatments already available internationally,” said Rachel Bartholomew, Founder and Lead Advisor, Femtech Canada. “Disparities in access to innovations in women’s health can significantly impact outcomes, quality of life, and overall long-term wellbeing of Canadian women.”

This study is the first to provide a quantitative evaluation of the main challenges involved in bringing innovative women’s health medications to Canada over the past 20 years. The research found that of the 45 women’s health medications approved by the U.S. Food and Drug Administration between 2003 and 2023 only 24 were approved in Canada. Even when medications do receive approval, the path to public coverage is resource-intensive and non-uniform. On average, it takes more than three years for a newly approved women’s health medication to appear on at least one Canadian public formulary, a full year longer than the average for other medications. Fewer than two-thirds of women’s health treatments approved by Health Canada are ultimately reimbursed through public drug plans.

“To ensure Canadian women have timely access to innovative therapies, it is essential to prioritize women’s health within Canada’s regulatory and reimbursement system,” said Catherine Beauchemin, Ph.D., partner at PeriPharm and co-author of the article. “We hope that these findings will help advance patient-centered policies and ultimately elevate the quality of care women receive across the country.”

Some of this study’s findings align with those of Azzarello D and Collins J. who, in 2004, conducted an analysis on access to hormonal contraceptive options in Canada¹. Following the Guidance for Industry: Clinical Development of Steroidal Contraceptives Used by Women issued by Health Canada on October 29, 2002, Canadian women had access to only 37% of the hormonal contraceptive choices available worldwide. Strikingly, this level of access has remained unchanged over the past two decades.

“Innovation is at the heart of Duchesnay, and I’m very proud to be part of a Canadian pharmaceutical company that invests in women’s health. This study shed the light on important evidence of the situation of women in Canada as funding remains limited,” said Édith Sirard, Director, Sales and Marketing, Duchesnay, and co-author of the article. “Modernizing the regulatory and reimbursement landscape is critical so that Canadian women can benefit from advances in care. At Duchesnay, we believe that women should have access to the most effective therapies available so that they can reach their full potential.”

The current study aims to lay the groundwork for a structural revision of current regulatory and reimbursement policies, while also facilitating in-depth discussions on key improvements, such as stronger recognition of women’s health needs, better integration of patient perspectives, and enhanced coordination between federal and provincial decision-makers, to drive meaningful changes across the healthcare ecosystem. Without such reforms, the decades long pattern of limited access to innovation in women’s health will likely persist.

ABOUT PERIPHARM

Founded in 2003, PeriPharm is a Canadian company specializing in pharmacoeconomics and outcomes research. The company’s mission is to provide high-quality, diversified services to ensure optimal market access of health care innovations. PeriPharm’s activity is built on the belief the best available therapies should be accessible to those who need it. As a leader in the field of health economics and data generation, PeriPharm has contributed to the success of several market access initiatives. 

For more information about PeriPharm, please visit https://peripharm.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY

Duchesnay is a specialty pharmaceutical company with a long-standing commitment to women’s health. Until recently, the company focused on filling the void in terms of scientific research and education and on developing pharmacological solutions that are safe and effective for use during pregnancy and breastfeeding.

Today, Duchesnay has broadened its portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives. Believing that women around the world deserve to have access to specialized treatments for their conditions, Duchesnay now distributes its products internationally. We strive to enable each woman to reach her full potential.

For more information about Duchesnay, please visit https://duchesnay.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY PHARMACEUTICAL GROUP

Duchesnay Pharmaceutical Group (DPG), with its affiliated companies, is headquartered in Blainville, Quebec. The Group consists of six pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad. The companies are Duchesnay (Canada) and Duchesnay USA, both dedicated to women’s health; Medunik Canada and Medunik USA, which provide treatments for rare and debilitating diseases; and Analog Pharma Canada and Analog Pharma, specializing in orphan generic medications. From its state-of-the-art manufacturing plant, DPG exports its innovative treatments to more than 50 countries.

DPG is one of the eight companies across the country chosen to participate in the Government of Canada’s Global Hypergrowth Project. This appointment offers exclusive and personalized support for at least two years, in order to accelerate its growth to become an anchor firm in the Canadian economy.

DPG is the winner of the 2024 Life Sciences Innovation Award by ADRIQ, the Association for the Development of Research and Innovation of Quebec, which recognizes DPG’s healthy workplace culture and commitment to pharmaceutical innovation, while DPG president Éric Gervais is the recipient of the 2024 Bernard-Landry Award by ADRIQ which acknowledges his impactful leadership on Quebec’s research and innovation ecosystem.

DPG, through its proprietary research and development, and through exclusive partnerships, offers innovative treatments for a variety of medical conditions in women’s health, urology, oncology and for rare diseases, plus lower-cost generic medications. DPG recognizes the dedication and professionalism of its employees and promotes a positive culture and flexible work environment. It is deeply committed to environmental responsibility and to giving back to the community through the support of various charitable organizations.

For more information, please visit https://duchesnaypharmaceuticalgroup.com/en.

Follow us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/duchesnay-and-peripharm-emphasize-the-need-to-update-regulatory-and-reimbursement-policies-to-improve-access-to-innovations-in-womens-health-302749510.html

SOURCE Duchesnay inc.

AnswerConnect’s commitment to planting trees proves businesses can deliver lasting environmental and social impact.

PORTLAND, Ore., April 22, 2026 /PRNewswire/ — On Earth Day 2026, AnswerConnect, a leader in business services across the US, Canada, and UK, announced that its One Tree One Planet initiative has planted 2 million trees, demonstrating how sustainability can be built into day-to-day business practices.

The company has released a video to celebrate the forests, communities, and people behind its 2 million trees. To learn more, visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ 

Demonstrating How Business Can Be a Force for Good

AnswerConnect plants one tree for every customer and employee every month, marking its dedication to reforestation and climate action. The initiative reflects a longstanding commitment to embedding business sustainability into daily operations.

More than a one-time initiative, the program is designed to grow continuously, with each new customer and employee contributing to its mission to give back to the planet.

“We’re a company built on human connection, and that extends beyond our customers and team,” said Natalie Ruiz, CEO of AnswerConnect. “Planting trees is one small way we invest in the world we all share.”

Collaborating With Environmental Organizations Across the Globe

The program is in partnership with a range of tree planters, including Friends of Pando, White Bark Pine Ecosystem, Save the Redwoods League, and, most notably, its core tree partner, Trees for the Future. The work carried out supports reforestation efforts that restore degraded land, strengthen local ecosystems, and help tackle carbon emissions, while also supporting farming communities in East Africa through agroforestry initiatives.

“Two million trees isn’t just planting, it represents so much more,” said Tim McLellan, CEO, Trees for the Future, “It’s thousands of farmers adopting sustainable land practices, it’s wildlife returning, microclimates developing, community livelihoods expanding, and carbon being sequestered.”

The impact of two million trees planted:

• Forest area created: ~4,000 acres (approximately 3,000 football fields)
• Carbon removed: ~44,000 metric tons of CO₂ per year (equivalent to removing 9,500 cars from the road)
• Oxygen produced: Supporting nearly 320,000 people annually
• Resource equivalence: Comparable to the production of roughly 100 million books

Proving Long-Term Corporate Sustainability is Possible and Scalable

With growing pressure on businesses to act sustainably, AnswerConnect shows how corporate social responsibility can be integrated into core operations in a way that lasts.

“What makes this milestone significant isn’t just the number, it’s the consistency behind it,” said Ruiz of AnswerConnect. “It marks our commitment to treating sustainability as part of how our business runs, not as a separate initiative.”

By building reforestation into its business model, the company has created a scalable framework for corporate climate action. Through planting trees and building partnerships that support communities and ecosystems around the world, AnswerConnect is committed to creating long-term impact that extends beyond its business and into the future. 

AnswerConnect has released a video showcasing the forests, communities, and the initiative’s long-term impact. Visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ to watch and learn more.

About AnswerConnect

Voted #1 answering service by Forbes, AnswerConnect integrates advanced technology with genuine human interaction, supporting businesses across the US, UK, and Canada to connect with their customers 24/7. Find out more at answerconnect.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/earth-day-milestone-2-million-trees-planted-as-answerconnect-shows-the-power-of-corporate-climate-action-302749869.html

SOURCE AnswerConnect

AnswerConnect’s commitment to planting trees proves businesses can deliver lasting environmental and social impact.

PORTLAND, Ore., April 22, 2026 /PRNewswire/ — On Earth Day 2026, AnswerConnect, a leader in business services across the US, Canada, and UK, announced that its One Tree One Planet initiative has planted 2 million trees, demonstrating how sustainability can be built into day-to-day business practices.

The company has released a video to celebrate the forests, communities, and people behind its 2 million trees. To learn more, visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ 

Demonstrating How Business Can Be a Force for Good

AnswerConnect plants one tree for every customer and employee every month, marking its dedication to reforestation and climate action. The initiative reflects a longstanding commitment to embedding business sustainability into daily operations.

More than a one-time initiative, the program is designed to grow continuously, with each new customer and employee contributing to its mission to give back to the planet.

“We’re a company built on human connection, and that extends beyond our customers and team,” said Natalie Ruiz, CEO of AnswerConnect. “Planting trees is one small way we invest in the world we all share.”

Collaborating With Environmental Organizations Across the Globe

The program is in partnership with a range of tree planters, including Friends of Pando, White Bark Pine Ecosystem, Save the Redwoods League, and, most notably, its core tree partner, Trees for the Future. The work carried out supports reforestation efforts that restore degraded land, strengthen local ecosystems, and help tackle carbon emissions, while also supporting farming communities in East Africa through agroforestry initiatives.

“Two million trees isn’t just planting, it represents so much more,” said Tim McLellan, CEO, Trees for the Future, “It’s thousands of farmers adopting sustainable land practices, it’s wildlife returning, microclimates developing, community livelihoods expanding, and carbon being sequestered.”

The impact of two million trees planted:

• Forest area created: ~4,000 acres (approximately 3,000 football fields)
• Carbon removed: ~44,000 metric tons of CO₂ per year (equivalent to removing 9,500 cars from the road)
• Oxygen produced: Supporting nearly 320,000 people annually
• Resource equivalence: Comparable to the production of roughly 100 million books

Proving Long-Term Corporate Sustainability is Possible and Scalable

With growing pressure on businesses to act sustainably, AnswerConnect shows how corporate social responsibility can be integrated into core operations in a way that lasts.

“What makes this milestone significant isn’t just the number, it’s the consistency behind it,” said Ruiz of AnswerConnect. “It marks our commitment to treating sustainability as part of how our business runs, not as a separate initiative.”

By building reforestation into its business model, the company has created a scalable framework for corporate climate action. Through planting trees and building partnerships that support communities and ecosystems around the world, AnswerConnect is committed to creating long-term impact that extends beyond its business and into the future. 

AnswerConnect has released a video showcasing the forests, communities, and the initiative’s long-term impact. Visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ to watch and learn more.

About AnswerConnect

Voted #1 answering service by Forbes, AnswerConnect integrates advanced technology with genuine human interaction, supporting businesses across the US, UK, and Canada to connect with their customers 24/7. Find out more at answerconnect.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/earth-day-milestone-2-million-trees-planted-as-answerconnect-shows-the-power-of-corporate-climate-action-302749869.html

SOURCE AnswerConnect

AnswerConnect’s commitment to planting trees proves businesses can deliver lasting environmental and social impact.

PORTLAND, Ore., April 22, 2026 /PRNewswire/ — On Earth Day 2026, AnswerConnect, a leader in business services across the US, Canada, and UK, announced that its One Tree One Planet initiative has planted 2 million trees, demonstrating how sustainability can be built into day-to-day business practices.

The company has released a video to celebrate the forests, communities, and people behind its 2 million trees. To learn more, visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ 

Demonstrating How Business Can Be a Force for Good

AnswerConnect plants one tree for every customer and employee every month, marking its dedication to reforestation and climate action. The initiative reflects a longstanding commitment to embedding business sustainability into daily operations.

More than a one-time initiative, the program is designed to grow continuously, with each new customer and employee contributing to its mission to give back to the planet.

“We’re a company built on human connection, and that extends beyond our customers and team,” said Natalie Ruiz, CEO of AnswerConnect. “Planting trees is one small way we invest in the world we all share.”

Collaborating With Environmental Organizations Across the Globe

The program is in partnership with a range of tree planters, including Friends of Pando, White Bark Pine Ecosystem, Save the Redwoods League, and, most notably, its core tree partner, Trees for the Future. The work carried out supports reforestation efforts that restore degraded land, strengthen local ecosystems, and help tackle carbon emissions, while also supporting farming communities in East Africa through agroforestry initiatives.

“Two million trees isn’t just planting, it represents so much more,” said Tim McLellan, CEO, Trees for the Future, “It’s thousands of farmers adopting sustainable land practices, it’s wildlife returning, microclimates developing, community livelihoods expanding, and carbon being sequestered.”

The impact of two million trees planted:

• Forest area created: ~4,000 acres (approximately 3,000 football fields)
• Carbon removed: ~44,000 metric tons of CO₂ per year (equivalent to removing 9,500 cars from the road)
• Oxygen produced: Supporting nearly 320,000 people annually
• Resource equivalence: Comparable to the production of roughly 100 million books

Proving Long-Term Corporate Sustainability is Possible and Scalable

With growing pressure on businesses to act sustainably, AnswerConnect shows how corporate social responsibility can be integrated into core operations in a way that lasts.

“What makes this milestone significant isn’t just the number, it’s the consistency behind it,” said Ruiz of AnswerConnect. “It marks our commitment to treating sustainability as part of how our business runs, not as a separate initiative.”

By building reforestation into its business model, the company has created a scalable framework for corporate climate action. Through planting trees and building partnerships that support communities and ecosystems around the world, AnswerConnect is committed to creating long-term impact that extends beyond its business and into the future. 

AnswerConnect has released a video showcasing the forests, communities, and the initiative’s long-term impact. Visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ to watch and learn more.

About AnswerConnect

Voted #1 answering service by Forbes, AnswerConnect integrates advanced technology with genuine human interaction, supporting businesses across the US, UK, and Canada to connect with their customers 24/7. Find out more at answerconnect.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/earth-day-milestone-2-million-trees-planted-as-answerconnect-shows-the-power-of-corporate-climate-action-302749869.html

SOURCE AnswerConnect

The company celebrates a meaningful milestone in its ongoing initiative to make a lasting impact within global communities

PORTLAND, Ore., April 22, 2026 /PRNewswire/ — ServiceForge, the 24/7 live answering and customer service platform built for skilled trades and home service businesses, announces a significant achievement in its ongoing sustainability drive: the company has now planted more than two million trees worldwide, a milestone reached in time for Earth Day 2026.

Each month, ServiceForge plants one tree for every employee and every customer. What began as a simple commitment to give back has grown into a meaningful, long-term impact effort, now surpassing a major milestone. This accomplishment reflects the company’s continued dedication to environmental stewardship and community-focused values.

For context, two million trees adds up to:

• Approximately 4,000 acres of forest
• Roughly 3,000 football fields
• Trees sufficient to remove an estimated 44,000 metric tons of CO₂ per year (equivalent of taking 9,500 cars off the road)

“This milestone reflects the kind of work we believe in: steady, intentional and rooted in real impact,” said Jane Blanchard, head of brand and marketing for ServiceForge. “In the skilled trades, success isn’t about quick wins; it’s about the slow, human work of strengthening homes, businesses and communities. Planting trees is a natural extension of that mission. It’s a way for us to contribute to something lasting, something that grows alongside the businesses we serve.”

ServiceForge partners with verified reforestation organizations that plant trees in areas affected by deforestation, wildfires and climate change. Partners include Trees for the Future, Save the Redwoods League and Friends of Pando, ensuring that each tree contributes to restoration efforts where it’s needed most.

“We’re in the business of fixing things,” Blanchard said. “What better way to exemplify that commitment than by planting trees, which clean the air, restore habitats and ultimately make the world a better place.”

For more information about ServiceForge and their Giving Back initiative, visit https://www.serviceforge.com/why-serviceforge/givingback

About ServiceForge
ServiceForge helps home service businesses get found, get booked and get paid with 24/7 human answering, scheduling, lead qualification and payments. By combining smart technology with real human connection, ServiceForge helps service businesses stand out in an increasingly disconnected world, ensuring contractors capture more jobs while delivering exceptional customer service. For more information, visit serviceforge.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/serviceforge-plants-two-million-trees-worldwide-302748866.html

SOURCE ServiceForge

The company celebrates a meaningful milestone in its ongoing initiative to make a lasting impact within global communities

PORTLAND, Ore., April 22, 2026 /PRNewswire/ — ServiceForge, the 24/7 live answering and customer service platform built for skilled trades and home service businesses, announces a significant achievement in its ongoing sustainability drive: the company has now planted more than two million trees worldwide, a milestone reached in time for Earth Day 2026.

Each month, ServiceForge plants one tree for every employee and every customer. What began as a simple commitment to give back has grown into a meaningful, long-term impact effort, now surpassing a major milestone. This accomplishment reflects the company’s continued dedication to environmental stewardship and community-focused values.

For context, two million trees adds up to:

• Approximately 4,000 acres of forest
• Roughly 3,000 football fields
• Trees sufficient to remove an estimated 44,000 metric tons of CO₂ per year (equivalent of taking 9,500 cars off the road)

“This milestone reflects the kind of work we believe in: steady, intentional and rooted in real impact,” said Jane Blanchard, head of brand and marketing for ServiceForge. “In the skilled trades, success isn’t about quick wins; it’s about the slow, human work of strengthening homes, businesses and communities. Planting trees is a natural extension of that mission. It’s a way for us to contribute to something lasting, something that grows alongside the businesses we serve.”

ServiceForge partners with verified reforestation organizations that plant trees in areas affected by deforestation, wildfires and climate change. Partners include Trees for the Future, Save the Redwoods League and Friends of Pando, ensuring that each tree contributes to restoration efforts where it’s needed most.

“We’re in the business of fixing things,” Blanchard said. “What better way to exemplify that commitment than by planting trees, which clean the air, restore habitats and ultimately make the world a better place.”

For more information about ServiceForge and their Giving Back initiative, visit https://www.serviceforge.com/why-serviceforge/givingback

About ServiceForge
ServiceForge helps home service businesses get found, get booked and get paid with 24/7 human answering, scheduling, lead qualification and payments. By combining smart technology with real human connection, ServiceForge helps service businesses stand out in an increasingly disconnected world, ensuring contractors capture more jobs while delivering exceptional customer service. For more information, visit serviceforge.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/serviceforge-plants-two-million-trees-worldwide-302748866.html

SOURCE ServiceForge